There is a pressing need to understand the social dimensions that add to disease burden in rheumatoid arthritis (RA) and potential synergistic interactions with biological parameters of disease, such as level of inflammation. The overarching aim of this study is to gather in-depth information on social determinants that drive refractory disease in RA, which could be used alongside ‘traditional’ disease management (i.e. drug therapy), to inform resource allocation and service redesign in line with national standards.
Project LeadE Nikiphorou
This study will provide a deep understanding into non-biological, social factors that drive active disease. This way, the study will provide evidence on how to best combine health and social resources to improve the care pathway of patients with RA, ensuring fair and equal access to all.